Who is the CEO of DNTH? | Glauxie AI

Q: Who is the CEO of DNTH?

Dianthus Therapeutics, Inc. (DNTH) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Marino Garcia. Dianthus Therapeutics, Inc. operates as a clinical-stage biotechnology company that designs, develops, and delivers novel monoclonal antibodies for people living with severe autoimmune and... Employees: 100,000.

Q: What does DNTH company do?

Learn what DNTH does — business model, products, services, revenue segments, and company history.

Q: Are insiders buying or selling DNTH?

Track recent insider buys and sells for DNTH with transaction details, amounts, and trends.

Q: What sector is DNTH in?

Find DNTH sector, industry, and sub-industry classification with sector peer comparison.

Who is the CEO of DNTH?

🦉

Dianthus Therapeutics, Inc. (DNTH)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOMarino Garcia

Dianthus Therapeutics, Inc. operates as a clinical-stage biotechnology company that designs, develops, and delivers novel monoclonal antibodies for people living with severe autoimmune and inflammatory diseases. It develops DNTH103 that is in phase 1 clinical trails in patients with generalized...

Key Executives

Name	Title
Adam Veness	Senior Vice President, General Counsel & Secretary
Debra Segal	Head of Regulatory Affairs
Edward G. Carr	Senior VP & Chief Accounting Officer
Jennifer Davis Ruff	Vice President and Head of Investor Relations & Corporate Affairs.
Judson Taylor	Senior Vice President & Head of Technical Operations
Kristina Maximenko	Chief People Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

DNTH Profile Financials

What does DNTH company do? Are insiders buying or selling DNTH? What sector is DNTH in?